当前位置: X-MOL 学术Cardiol. Rev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A Nonsurgical Approach to Mesenteric Vascular Disease.
Cardiology in Review ( IF 2.1 ) Pub Date : 2018-2-9 , DOI: 10.1097/crd.0000000000000180
Hossein Tabriziani , Armaghan Ahmad , Deepika Narasimha , Roberto Bergamaschi , William H Frishman

Mesenteric ischemia is a rare disorder, with considerably high morbidity and mortality rates. It can manifest in several ways, including acute mesenteric ischemia, chronic mesenteric ischemia, nonocclusive mesenteric ischemia, mesenteric venous thrombosis, and colonic ischemia. Of these, acute mesenteric ischemia is the most severe form of intestinal ischemia, with a high mortality rate. The mainstay of therapy for mesenteric ischemia is surgical exploration and resection of infarcted bowel; however, medical therapy can play an important adjunctive role. When diagnosed early, before bowel infarction, endovascular therapy can be used as the primary treatment option. Endovascular therapy includes catheter-based thrombolysis, thromboembolectomy, and stenting. Vasodilators also play an important role in the early management of mesenteric ischemia. Anticoagulation is the main form of therapy in mesenteric venous thrombosis.

中文翻译:

肠系膜血管疾病的非手术方法。

肠系膜缺血是一种罕见的疾病,发病率和死亡率很高。它可以几种方式表现出来,包括急性肠系膜缺血,慢性肠系膜缺血,非闭塞性肠系膜缺血,肠系膜静脉血栓形成和结肠缺血。其中,急性肠系膜缺血是肠道缺血的最严重形式,死亡率很高。肠系膜缺血的主要治疗手段是手术探查和切除梗死肠。但是,药物治疗可以起重要的辅助作用。如果在肠梗死之前及早诊断,血管内治疗可以作为主要治疗选择。血管内治疗包括基于导管的溶栓,血栓栓塞切除术和支架置入术。血管扩张剂在肠系膜缺血的早期治疗中也起着重要作用。
更新日期:2020-12-17
down
wechat
bug